1. Home
  2. VTRS vs RTO Comparison

VTRS vs RTO Comparison

Compare VTRS & RTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTRS
  • RTO
  • Stock Information
  • Founded
  • VTRS 1961
  • RTO 1925
  • Country
  • VTRS United States
  • RTO United Kingdom
  • Employees
  • VTRS N/A
  • RTO N/A
  • Industry
  • VTRS Medicinal Chemicals and Botanical Products
  • RTO Business Services
  • Sector
  • VTRS Health Care
  • RTO Consumer Discretionary
  • Exchange
  • VTRS Nasdaq
  • RTO Nasdaq
  • Market Cap
  • VTRS 14.0B
  • RTO 13.1B
  • IPO Year
  • VTRS N/A
  • RTO N/A
  • Fundamental
  • Price
  • VTRS $11.30
  • RTO $23.85
  • Analyst Decision
  • VTRS Hold
  • RTO Hold
  • Analyst Count
  • VTRS 3
  • RTO 2
  • Target Price
  • VTRS $13.67
  • RTO $29.00
  • AVG Volume (30 Days)
  • VTRS 10.6M
  • RTO 595.1K
  • Earning Date
  • VTRS 02-26-2025
  • RTO 01-28-2025
  • Dividend Yield
  • VTRS 4.25%
  • RTO 2.44%
  • EPS Growth
  • VTRS N/A
  • RTO 24.34
  • EPS
  • VTRS N/A
  • RTO 0.20
  • Revenue
  • VTRS $15,048,500,000.00
  • RTO $6,837,109,965.00
  • Revenue This Year
  • VTRS N/A
  • RTO $4.06
  • Revenue Next Year
  • VTRS N/A
  • RTO $2.81
  • P/E Ratio
  • VTRS N/A
  • RTO $23.88
  • Revenue Growth
  • VTRS N/A
  • RTO 12.40
  • 52 Week Low
  • VTRS $9.93
  • RTO $22.40
  • 52 Week High
  • VTRS $13.62
  • RTO $34.07
  • Technical
  • Relative Strength Index (RSI)
  • VTRS 28.18
  • RTO 39.23
  • Support Level
  • VTRS $11.13
  • RTO $23.25
  • Resistance Level
  • VTRS $12.02
  • RTO $23.95
  • Average True Range (ATR)
  • VTRS 0.32
  • RTO 0.42
  • MACD
  • VTRS -0.09
  • RTO -0.09
  • Stochastic Oscillator
  • VTRS 10.97
  • RTO 25.64

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

About RTO Rentokil Initial plc

Rentokil Initial is the largest global provider of route-based pest-control and commercial hygiene services, operating in 83 countries. The group also offers a range of specialist route-based services including office and commercial space plant care, property care, and workwear rentals. The group has a diverse client base that includes global food producers, hotel chains, industrial goods businesses, restaurants, and individual residential customers.

Share on Social Networks: